Aytemiz Gürgey1, Sevgi Yetgin, Mualla Cetin
1Section of Hematology, Department of Pediatrics, Hacettepe University, Faculty of Medicine, Ankara, Turkey.
Treatment for infant acute lymphoblastic leukemia (ALL) improved significantly over time. Newer protocols (Total Therapy XI and XIII) demonstrated better event-free survival rates compared to earlier regimens.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: